FREE patent keyword monitoring and additional FREE benefits. /images/triangleright (1K) REGISTER now for FREE triangleleft (1K)
Fresh Patents
Monitor Patents Patent Organizer How to File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations


Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Oxygen Containing Hetero Ring > The Hetero Ring Is Five-membered > Chalcogen Bonded Directly To The Hetero Ring > Ascorbic Acid Or Derivative (e.g., Vitamin C, Etc.)

Ascorbic Acid Or Derivative (e.g., Vitamin C, Etc.)

Ascorbic Acid Or Derivative (e.g., Vitamin C, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.

10/12/06 - 20060229360 - Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins c and k3
A combination of Vitamin C and a quinone used as a supplemental treatment for a cancer patient. The combination may be administered before, during and after the patient undergoes a conventional cancer treatment protocol. The combination may be administered orally, intravenously, or intraperitoneally. Oral administration may be in the form ...

07/20/06 - 20060160891 - Process for producing powdered compositions containing highly unsaturated fatty acid esters of ascorbic acid and powdered compositions containing the esters
The invention provides a process for powdering highly unsaturated fatty acid esters of ascorbic acid which are pasty and problematic in physical properties by a simple and easy means; highly unsaturated fatty acid esters of ascorbic acid which are improved in stability by powdering; and compositions containing the powdered highly ...

06/29/06 - 20060142382 - Skin lightening composition
A composition which comprises (i) tranexamic acid or a salt thereof, (ii) L-cysteine, a derivative thereof or a salt thereof and, as occasion demands, (iii) L-ascorbic acid, a derivative thereof or a salt thereof. ...

03/16/06 - 20060058378 - Reduced bioirritant composition
A method for reducing irritancy of ascorbic acid administered to a biological surface for anti-angiogenic, anti-oxidant, anti-inflammatory and other effects. It has been discovered that pH neutralized ascorbic acid retains the efficacy of non-pH neutralized ascorbic acid in reducing neovascularization, providing an anti-oxidant effect, etc. but is less irritating and ...

02/09/06 - 20060030621 - Preparation for external use on skin
The present invention has as an object to provide a preparation for external use on skin in which the percutaneous absorption amount of ascorbic acid or an ascorbic acid derivative is increased and an effect on improving skin pigmentation and dullness is enhanced. In a preparation for external use on ...

02/09/06 - 20060030620 - Method for treating and/or preventing ischemia/reperfusion injury
Magnesium ascorbate, a previous Romanian cardio protective drug, is provided to alleviate ischemia/reperfusion injury. In particular, the present invention relates to a pharmaceutical composition of magnesium ascorbate for treating and/or preventing liver ischemia/reperfusion injure in mammals. ...

01/05/06 - 20060004089 - Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye
Use of a salt of L-ascorbic acid with a pharmaceutically acceptable organic base to prepare a pharmaceutical composition, for ophthalmic topical use, capable of improving the level of L-ascorbic acid in a human eye. ...

11/17/05 - 20050256186 - Prevention of and countermeasures against mitochondrial disease
The present invention relates to an agent containing L-arginine, 0.2 to 20 parts by weight of L-ascorbic acid per 1 part by weight of L-arginine, and, if desired, at least one selected from the group consisting of ribonucleic acids, ribonucleotides and ribonucleosides. The agent can treat mitochondrial disease which shows ...

10/20/05 - 20050234122 - Prevention of and countermeasures against viral infection
The present invention relates to a method for preventing vial infection, which includes administering arginine and a high dose of vitamin C. It also relates to an agent for preventing vial infection, which includes arginine and coated vitamin C. According to the present invention, a subject can be efficaciously prevented ...

09/15/05 - 20050203175 - Parenteral composition of paracetamol
The present invention refers to a pharmaceutical preparation, comprising a novel, stable solution of Paracetamol for parenteral administration, useful to establish an analgesic and antipyretic effect. ...

08/25/05 - 20050187290 - Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
The invention relates to the technical fields of biology, pharmacology and medicine. The invention is suitable for use in particular in the human and animal health fields. More specifically, the invention relates to the use of a cAMP modulator in the preparation of compositions that are intended for the prevention ...

07/14/05 - 20050154054 - Stabilized ascorbic acid compositions and methods therefor
The present invention relates to ascorbic acid single-phase solution compositions that provide enhanced stability, enhanced solubility and an enhanced photoprotective effect as compared to prior compositions. The compositions comprise L-ascorbic acid; a cinnamic acid derivative such as p-coumaric acid, ferulic acid, caffeic acid, sinapinic acid, a derivative thereof, and a ...

07/07/05 - 20050148660 - Novel retinol derivative and cosmetic composition comprising the same
The present invention relates to a novel retinol derivative and a cosmetic composition comprising the same, in particular, to a novel retinol derivative represented by the formula (I) exhibiting the effects from both L-ascorbic acid and retinol as well as being free from the disadvantages of two compounds such as ...



###

FreshPatents.com Support